SANOVEL Trademark

Trademark Overview


On Tuesday, October 9, 2012, a trademark application was filed for SANOVEL with the United States Patent and Trademark Office. The USPTO has given the SANOVEL trademark a serial number of 85749420. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, July 3, 2020. This trademark is owned by SANOVEL ILAÇ SANAYI VE TICARET ANONIM SIRKETI. The SANOVEL trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations for the treatment of cardiovascular disorders, skeleto-muscular disorders, general infections, viral infections, central nervous system disorders, gastro-intestinal disorders, fungal diseases, erectile dysfunction, respiratory diseases, allergy, ophthalmic diseases, containing one or more of the following active ingredients - cromolin sodium, amlodipin besylate, alendronate sodium, chlorazepate dipotassium, atropine sulphate, atorvastatin calcium, candesartan cilexetil, ceftriaxone sodium, ephedrine hcl, guaiphenesine, zafirlukast, donepezil hcl, diflunisal, dipyridamole, famotidine, losartan potassium, hydro-chlorothiazide, meloxicam, phenyleprine hcl, fexofenadine hcl, indapamide, sulfisoxazole, clopidogrel, lansoprazole, clarithromycin, flurbiprofen, nimesulide, pantoprazole, paracetamole, pilocarpine hcl, lisinopril, pseudoephedrine hcl, ciprofloxacin hcl, sertraline hcl, cyclopentolate hcl, dihydroergotoxine methansulfonate, terbinafine, timolol maleate...
sanovel

General Information


Serial Number85749420
Word MarkSANOVEL
Filing DateTuesday, October 9, 2012
Status710 - CANCELLED - SECTION 8
Status DateFriday, July 3, 2020
Registration Number4438655
Registration DateTuesday, November 26, 2013
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 10, 2013

Trademark Statements


Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and Servicespharmaceutical preparations for the treatment of cardiovascular disorders, skeleto-muscular disorders, general infections, viral infections, central nervous system disorders, gastro-intestinal disorders, fungal diseases, erectile dysfunction, respiratory diseases, allergy, ophthalmic diseases, containing one or more of the following active ingredients - cromolin sodium, amlodipin besylate, alendronate sodium, chlorazepate dipotassium, atropine sulphate, atorvastatin calcium, candesartan cilexetil, ceftriaxone sodium, ephedrine hcl, guaiphenesine, zafirlukast, donepezil hcl, diflunisal, dipyridamole, famotidine, losartan potassium, hydro-chlorothiazide, meloxicam, phenyleprine hcl, fexofenadine hcl, indapamide, sulfisoxazole, clopidogrel, lansoprazole, clarithromycin, flurbiprofen, nimesulide, pantoprazole, paracetamole, pilocarpine hcl, lisinopril, pseudoephedrine hcl, ciprofloxacin hcl, sertraline hcl, cyclopentolate hcl, dihydroergotoxine methansulfonate, terbinafine, timolol maleate, tiamphenicol, azithromycin, tenoxicam, fluconazole, digoxine, tioconazole, dimenhydrinate, quinidine arabogalactane sulphate, quinidine phenylethyl barbiturate, diltiazem hcl, buspirone hcl, amiodarone hcl, trazodone, difluprednate, enoxacin, lactulose, ketorolac, pentoxifylline, vitamin e, chlorhexidine, cetrimide, propyphenazone, caffeine, cetirizine, phenylpropanolamine, zolpidem, bacampicillin hcl, roxithromycin, sultamicillin tosilate, acetylsalicylic acid, ampicillin na, sulbactam na, sildenafil citrate, ambroxol hcl, ribavirin, loratadine, etodolac, omeprazole, oxybutynin chloride, quinidine sulphate, olanzapine, raloxifen, pioglitazone, moxifloxacin, rosiglitazone, sibutramin, carvedilol, montelukast, citalopram, gliclazide, cefaclor, ezetimibe, rofecoxib, quetiapine fumarate, metformin hcl, acarbose, chlorpheniramine maleate, nateglinide, leflunomide, valsartan, cefazolin sodium, diacerein, paroxetine, levofloxacin, levetiracetam, zolmitriptan, glibenclamide, tizanidine, perindopril erbumine, ramipril, ceftazidime, cefuroxime axetyl, thiocolchicoside, acamprosate, acetylcysteine, alpha calcidol, alpha lipoic acid, aripiprazole, atomoxetine, balsalazide disodium, butenafine hcl, calcitriol, carbonyl iron, folic acid, calcium carbonate, magnesium hydroxide, cefdinir, cefepime hcl, cefixime, cefpodoxime proxetil, cefprozil, cephalexine monohydrate, ciclesonide, cilazapril, cilostazol, cinitapride, citicoline, co-enzyme q10, darifenasin, deferiprone, dothiepin, duloxetine, eletriptan, escitalopram, esomeprazole, etoricoxib, felodipine, fenofibrate, ferrous sulphate, zinc sulphate, fluvastatin, frovatriptan, gabapentin, galantamine, gemifloxacin, ginkgo biloba, glimepride, granisetron, ibandronate, irbesartan, iron hydroxide polymaltose, lamivudine, lamotrigine, levetiracetam, letrozole, linezolide, memantine hcl, metoprolol, midodrine, mirtazapine, mizolastine, mosapride citrate dihydrate, mycophenolate mofetil, nebivolol, nefazodone, niacin, nitazoxanide, ondansetron, ornidazole, oxcarbazepine, pimecrolimus, pravastatin, pregabalin, rabeprazol, rebamipide, repaglinide, risedronate, risperidone, rivastigmine, rosuvastatin, saccharomyces boulardii, tacrolimus, tadalafil, tamsulosin hcl, tazaroten, tazobactam sodium, piperacillin sodium, tegaserod, telithromycin, terazocin, teriparatide, tolterodine tartrate, topiramate, trandolapril, trimethazidine, valacyclovir, valproate sodium, venlafaxine, voriconazole, ximelagatran, zaleplon, ziprasidone, zoledronic acid

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, July 3, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSANOVEL ILAÇ SANAYI VE TICARET ANONIM SIRKETI
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressIstanbul 34398Masl
TR

Party NameSANOVEL ILAÇ SANAYI VE TICARET ANONIM SIRKETI
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressIstanbul 34398Masl
TR

Party NameSANOVEL ILAÇ SANAYI VE TICARET ANONIM SIRKETI
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIstanbul 34398Masl
TR

Trademark Events


Event DateEvent Description
Friday, July 3, 2020CANCELLED SEC. 8 (6-YR)
Monday, November 26, 2018COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, November 26, 2013REGISTERED-PRINCIPAL REGISTER
Tuesday, September 10, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 10, 2013PUBLISHED FOR OPPOSITION
Wednesday, August 21, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, August 7, 2013LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, August 6, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, August 6, 2013AMENDMENT FROM APPLICANT ENTERED
Tuesday, August 6, 2013CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, August 1, 2013PAPER RECEIVED
Thursday, February 7, 2013COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION ENTERED
Wednesday, February 6, 2013ASSIGNED TO LIE
Wednesday, February 6, 2013NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Wednesday, February 6, 2013EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Wednesday, February 6, 2013EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
Wednesday, February 6, 2013ASSIGNED TO EXAMINER
Tuesday, December 11, 2012TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, October 16, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, October 12, 2012NEW APPLICATION ENTERED IN TRAM